AMLN: Message Board for Amylin Pharmaceuticals, Inc. | Forum profile

Recs: 0 Re: Groan-kevinhicup has returned Kevin Put co3aii on ignore and don't take him of ignore until the stock reaches $150.. zino thread start

Recs: 0 Re: Groan-kevinhicup has returned Listen you bloviating moron you and others posted that comment as per Foletta. Why don't you call Mark, make sure while you're sober, and tell him what he should do with Lilly. Keep in mind he answered the question and if push comes to shove we are free of those clowns. Just make dure you can stop drinking long enough to have a ...

Recs: 3 Close Concern Hitting the panic button – diabetes, Byetta, and pancreatitis So there have been a lot of headlines lately about Byetta and pancreatitis. We think these headlines have created unnecessary alarm for patients and believe that the facts haven’t been well stated. Thirty-six patients have reported pancreatits, including six that have died. But more than...

Recs: 0 Re: Groan-kevinhicup has returned Are you saying that LIlly's Once a Week GLP-1 Program in Phase II & III clinical trials is essentially nothing ? Let me repeat it again, Lilly's ONCE A WEEK GLP-1 PROGRAM sure sound a lot like EXENATIDE ONCE A WEEK PROGRAM doesn't it. So please stick you head back in the hole in the ground and keep pretending everything is ...

Recs: 0 Groan-kevinhicup has returned Hey kev, 14 posts that said essentially nothing. Get a grip. See you at $150, the best is yet to come.

Recs: 0 Obtaining information about adverse event reports is no longer available to everyone and is only an invitation basis only Iconfinalslogan Back to Basic Search Home Signed in as guest Sign In here Find Adverse Event Cases _help Fuzzy Search? DRUG NAME MANUFACTURER NAME DRUG INDICATION EVENT DESCRIPTION OUTCOME CODE DRUG'...

Recs: 1 Re: The chants must begin.. Joe must go...Joe must go...Joe must go... Joe must go... [Horsecrap!!!] "Remember, Joe Cook's own money saved this company from extinction. " - Joe may have contributed some of his own dollars, but he made a hell of a lot more money off the Amylin stock options he received at penny stock levels right after he became CEO. Also when ...

Recs: 3 Re: The chants must begin.. Joe must go...Joe must go...Joe must go... Joe must go... [Horsecrap!!!] Kevin the Whiner: Kindly rein in your sophomoric blathering. You are almost singlehandedly ruining what was once the best stock board on Investor Village. Remember, Joe Cook's own money saved this company from extinction. Also, Joe Cook ran ...

Recs: 0 Re: The chants must begin.. Joe must go...Joe must go...Joe must go... Joe must go... he chants must begin.. Joe must go...Joe must go...Joe must go... Joe must go... That may be an overraction...Takasugi never really hurt anyone thread start

Recs: 1 I sent the followig email to Amylin Investment Relations Department today. As an Amylin shareholder fo 10 years, I am concerned about the recent news that Lilly has moved its own Once a Week GLP-1 drug candidate into Phase II & Phase III. This appears to be a major conflict of interest against the collaboration agreement they signed with Amylin for the development ...

Recs: 5 Key Graph from ACCORD Trial showing Exenetide (Byetta) safety that was all Dan Needed to show last week

Recs: 0 More from the FDA Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) What is FDA posting? The following reports list any potential signals of serious risks/new safety information that were identified using the AERS database during the indicated quarter. The appearance of a drug on this list does not...

Recs: 0 The FDA posted the following on their website trying to explain their actions ! FDA News FOR IMMEDIATE RELEASE September 5, 2008 Media Inquiries: Christopher DiFrancesco, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA to Post Quarterly Report of Potential Safety Issues The U.S. Food and Drug Administration announced today that it has posted on...

Recs: 2 Re: According to Mark Foletta, expanding Symlin outside the U.S. is a low priority for the company ! Obesity drugs are about the most difficult drugs to get approved. The FDA concern is that the patient will take the drug for life once they start. Safety studies conducted by drug companies typically last much less than a year. If the FDA had any concern about ...

Recs: 3 Re: I sent the following email to Mike Huckman at CNBC Surprise, surprise, the FDA is loaded with people who have been compromised by conflicts of interest. Almost every doctor and scientist that works for the FDA is also associated with drug trials and development for one or more companies. This is often through grants or a subcontractor relationship with the ...

Recs: 2 FDA action on liraglutide FDA schedules Advisory Committee meeting for liraglutide (5 September 2008) Read in PDF format Novo Nordisk today announced that the Food and Drug Administration (FDA) has informed the company that an FDA Advisory Committee meeting is ...

Recs: 5 I sent the following email to Mike Huckman at CNBC I have a real problem with the FDA's August 18th safety alert for Byetta considering there was clearly no immediate need to issue the alert, let alone any evidence justifying it. So why did the FDA do it ? It clearly looks like there may be more going on at the agency then safety prevention for the public and I ...

Recs: 20 Re: 4 Deaths in 65 Patients Receiving Januvia...1 Died from Pancreatic Cancer...Doesn't This Deserve the Same Headline Treatment as Byetta? I'm surprised Merck even ran this trial. These people were quite ill, so the risk of fatalities was much higher than the general population. If patients had developed renal insuffiency AFTER initiating Januvia the ...

Recs: 8 Re: where is the stock heading ? I will wager $1000 against a box of doughnuts that you are NOT an endocrinologist. I will further wager that you have virtually no scientific training whatsoever. Poseurs like you are too easy to spot. BTW, contrary to your claim I have seen not a single person on this site post that there is a correlation between Byetta ...

Recs: 0 Re: If the stars are lined up properly Amylin could deliver a one, two punch to the pesty shorts in September 2008. The first knock down blow in October 2008. A second staggering blow by December 2008. The final knock out in 2009. The events I posted are far from being defensive and are actually the offensive moves we have been missing and need to get things ...